These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736 [TBL] [Abstract][Full Text] [Related]
27. [The pharmacological basis of the serotonin system: Application to antidepressant response]. David DJ; Gardier AM Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704 [TBL] [Abstract][Full Text] [Related]
28. Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment. de Montigny C; Blier P; Chaput Y Neuropharmacology; 1984 Dec; 23(12B):1511-20. PubMed ID: 6396527 [No Abstract] [Full Text] [Related]
29. Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors. Romero L; Bel N; Casanovas JM; Artigas F Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():1-8. PubMed ID: 8923121 [TBL] [Abstract][Full Text] [Related]
30. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Gobert A; Millan MJ Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475 [TBL] [Abstract][Full Text] [Related]
31. [Antidepressants, stressors and the serotonin 1A receptor]. Kirilly E; Gonda X; Bagdy G Neuropsychopharmacol Hung; 2015 Jun; 17(2):81-9. PubMed ID: 26192901 [TBL] [Abstract][Full Text] [Related]
32. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. Blier P; Szabo ST J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034 [TBL] [Abstract][Full Text] [Related]
33. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents. Dubovsky SL J Clin Psychiatry; 1994 Feb; 55 Suppl():34-44. PubMed ID: 8077173 [TBL] [Abstract][Full Text] [Related]
34. The neuropharmacology of serotonin and noradrenaline in depression. Nutt DJ Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606 [TBL] [Abstract][Full Text] [Related]
35. Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. Dale E; Pehrson AL; Jeyarajah T; Li Y; Leiser SC; Smagin G; Olsen CK; Sanchez C CNS Spectr; 2016 Apr; 21(2):143-61. PubMed ID: 26346726 [TBL] [Abstract][Full Text] [Related]
36. Alterations of serotonin transmission in schizophrenia. Abi-Dargham A Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. Horacek J; Bubenikova-Valesova V; Kopecek M; Palenicek T; Dockery C; Mohr P; Höschl C CNS Drugs; 2006; 20(5):389-409. PubMed ID: 16696579 [TBL] [Abstract][Full Text] [Related]